Pfizer Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was USD 100,330 million compared to USD 81,288 million a year ago. Net income was USD 31,372 million compared to USD 21,979 million a year ago.

Basic earnings per share from continuing operations was USD 5.59 compared to USD 4 a year ago. Diluted earnings per share from continuing operations was USD 5.47 compared to USD 3.93 a year ago. Basic earnings per share was USD 5.59 compared to USD 3.92 a year ago.

Diluted earnings per share was USD 5.47 compared to USD 3.85 a year ago.